ATE474555T1 - Aerosol-zusammensetzung - Google Patents

Aerosol-zusammensetzung

Info

Publication number
ATE474555T1
ATE474555T1 AT99913508T AT99913508T ATE474555T1 AT E474555 T1 ATE474555 T1 AT E474555T1 AT 99913508 T AT99913508 T AT 99913508T AT 99913508 T AT99913508 T AT 99913508T AT E474555 T1 ATE474555 T1 AT E474555T1
Authority
AT
Austria
Prior art keywords
particulate material
aerosol composition
mum
propellant
particles
Prior art date
Application number
AT99913508T
Other languages
English (en)
Inventor
Paul Alfred Dickinson
Simon John Warren
Original Assignee
Univ Cardiff
Cardiff Scintigraphics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10829846&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE474555(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Cardiff, Cardiff Scintigraphics Ltd filed Critical Univ Cardiff
Application granted granted Critical
Publication of ATE474555T1 publication Critical patent/ATE474555T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT99913508T 1998-04-03 1999-04-01 Aerosol-zusammensetzung ATE474555T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9807232.5A GB9807232D0 (en) 1998-04-03 1998-04-03 Aerosol composition
PCT/GB1999/001019 WO1999051205A1 (en) 1998-04-03 1999-04-01 Aerosol composition

Publications (1)

Publication Number Publication Date
ATE474555T1 true ATE474555T1 (de) 2010-08-15

Family

ID=10829846

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99913508T ATE474555T1 (de) 1998-04-03 1999-04-01 Aerosol-zusammensetzung

Country Status (17)

Country Link
US (2) US6737044B1 (de)
EP (1) EP1069887B8 (de)
JP (1) JP2002510614A (de)
KR (1) KR20010072563A (de)
CN (1) CN1215832C (de)
AT (1) ATE474555T1 (de)
AU (1) AU761518B2 (de)
BR (1) BR9909394A (de)
CA (1) CA2327336C (de)
DE (1) DE69942606D1 (de)
ES (1) ES2349184T3 (de)
GB (1) GB9807232D0 (de)
ID (1) ID27586A (de)
IL (1) IL138770A0 (de)
MX (1) MXPA00009660A (de)
WO (1) WO1999051205A1 (de)
ZA (1) ZA200005374B (de)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9807232D0 (en) 1998-04-03 1998-06-03 Univ Cardiff Aerosol composition
DE19921693A1 (de) 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
GB9928311D0 (en) * 1999-11-30 2000-01-26 Novartis Ag Organic compounds
AU5858501A (en) * 2000-05-23 2001-12-03 Glaxo Group Ltd Aerosol container for formulations of salmeterol xinafoate
GB0015043D0 (en) * 2000-06-21 2000-08-09 Glaxo Group Ltd Medicament dispenser
US20040081627A1 (en) * 2000-10-09 2004-04-29 Jinks Phillip A Medicinal aerosol formulations
NZ526564A (en) * 2000-12-22 2004-12-24 Glaxo Group Ltd Metered dose inhaler for salmeterol xinafoate
DE60221640T2 (de) * 2001-02-06 2008-05-21 Innovata Biomed Ltd., St. Albans Bimodale trockenpulverzusammensetzung zur inhalation
BR0208012A (pt) * 2001-03-20 2004-03-02 Glaxo Group Ltd Usos de pelo menos duas drogas e um propelente hfa e de pelo menos uma composição farmaceêutica, e, inalador acondicionado para tratar asma
EP1487417A4 (de) * 2001-09-17 2010-03-17 Glaxo Group Ltd Medikamentöse trockenpulver-formulierungen
CN1642524B (zh) * 2002-03-12 2011-05-18 微计量治疗公司 通过吸入部位特异性递送联合施用的药物
GB0219512D0 (en) * 2002-08-21 2002-10-02 Norton Healthcare Ltd Inhalation compositions with high drug ratios
US8273331B2 (en) * 2002-08-21 2012-09-25 Norton Healthcare Ltd. Inhalation compositions
US20050158248A1 (en) * 2002-08-21 2005-07-21 Xian-Ming Zeng Method of preparing dry powder inhalation compositions
GB0219511D0 (en) * 2002-08-21 2002-10-02 Norton Healthcare Ltd Method of preparing dry powder inhalation compositions
WO2004022142A1 (en) * 2002-09-06 2004-03-18 3M Innovative Properties Company Metering valve for a metered dose inhaler providing consistent delivery
GB0221343D0 (en) * 2002-09-16 2002-10-23 3M Innovative Properties Co Aerosol dispensers and adaptors therefor
US7497214B2 (en) * 2002-09-16 2009-03-03 3M Innovative Properties Company Aerosol dispensers and adaptors therefor
US7638138B2 (en) 2003-02-21 2009-12-29 Translational Research, Ltd. Compositions for nasal administration of pharmaceuticals
USRE45404E1 (en) 2003-03-27 2015-03-03 Shin Nippon Biomedical Laboratories, Ltd. Powder medicine applicator for nasal cavity
EP1641682B1 (de) * 2003-06-24 2011-01-05 Cipla Limited Vorrichtung zum abgeben von pharmazeutischen produkten
SE0303179D0 (sv) * 2003-11-26 2003-11-26 Astrazeneca Ab Novel compounds
WO2005051511A1 (ja) * 2003-11-28 2005-06-09 Mitsubishi Chemical Corporation 有機化合物微粒子の製造方法
DE102004011381A1 (de) * 2004-03-05 2005-09-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Impaktionsdüse für treibgasbetriebene Dosieraerosole
CA2567334A1 (en) * 2004-05-20 2005-12-08 Discovery Laboratories, Inc. Methods , systems and devices for noninvasive pulmonary delivery
GB0501956D0 (en) * 2005-01-31 2005-03-09 Arrow Internat Nebulizer formulation
US8028697B2 (en) 2005-04-28 2011-10-04 Trudell Medical International Ventilator circuit and method for the use thereof
US20060260606A1 (en) * 2005-05-18 2006-11-23 Coifman Robert E Inhalable formulations of amphotericin B and methods and devices for delivery thereof
US8367734B1 (en) 2005-08-11 2013-02-05 Amphastar Pharmaceuticals Inc. Stable epinephrine suspension formulation with high inhalation delivery efficiency
DE102006014433A1 (de) * 2006-03-27 2007-10-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Dosieraerosole für die Verabreichung von pharmazeutischen Zubereitungen
US20080269347A1 (en) * 2006-09-28 2008-10-30 Azopharma, Inc. Epinephrine formulations
ES2652415T3 (es) 2006-12-26 2018-02-02 Shin Nippon Biomedical Laboratories, Ltd. Preparación para aplicación transnasal
US20080202627A1 (en) * 2007-02-23 2008-08-28 Mas Gregory V Dosing System and Method
EP2534957B1 (de) 2007-12-14 2015-05-27 AeroDesigns, Inc Abgabe von Aerosol-sprühbaren Produkten
EP2100598A1 (de) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung
EP2100599A1 (de) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung
PL2265309T3 (pl) * 2008-03-17 2016-06-30 Discovery Lab Inc Adapter obwodu oddechowego i proksymalny system podawania aerozolu
CA2683353C (en) 2008-10-22 2015-12-15 Trudell Medical International Modular aerosol delivery system
JP5671001B2 (ja) 2009-03-26 2015-02-18 パルマトリックス,インコーポレイテッド 肺疾患を治療するための乾燥粉末製剤および方法
US9101539B2 (en) 2009-05-15 2015-08-11 Shin Nippon Biomedical Laboratories, Ltd. Intranasal pharmaceutical compositions with improved pharmacokinetics
US8827946B2 (en) 2009-07-31 2014-09-09 Shin Nippon Biomedical Laboratories, Ltd. Intranasal granisetron and nasal applicator
AU2010324997A1 (en) 2009-11-24 2012-05-31 Gilead Sciences, Inc. Inhaled fosfomycin/tobramycin for the treatment of chronic obstructive pulmonary disease
WO2011081937A1 (en) 2009-12-15 2011-07-07 Gilead Sciences, Inc. Corticosteroid-beta-agonist-muscarinic antagonist compounds for use in therapy
CN102665807A (zh) 2010-01-05 2012-09-12 微剂量治疗技术公司 吸入设备和方法
WO2011143106A1 (en) 2010-05-10 2011-11-17 Gilead Sciences, Inc. Bi - functional pyrazolopyridine compounds
US8394829B2 (en) 2010-05-10 2013-03-12 Gilead Sciences, Inc. Bi-functional quinoline analogs
WO2012030664A1 (en) 2010-08-30 2012-03-08 Pulmatrix, Inc. Dry powder formulations and methods for treating pulmonary diseases
US8758824B2 (en) 2010-08-30 2014-06-24 Pulmatrix, Inc. Respirably dry powder comprising calcium lactate, sodium chloride and leucine
CN102416179B (zh) 2010-09-28 2014-05-07 益得生物科技股份有限公司 用于哮喘的吸入性复方组合物
PT2621488T (pt) 2010-09-29 2019-02-12 Pulmatrix Operating Co Inc Pós secos catiónicos
EP4008326A1 (de) 2010-09-29 2022-06-08 Pulmatrix Operating Company, Inc. Einwertige metallkationen-trockenpulver zum inhalieren
FR2971772B1 (fr) * 2011-02-17 2013-03-22 Valois Sas Dispositif de distribution de produit fluide.
TWI399202B (zh) 2011-03-17 2013-06-21 Intech Biopharm Ltd 製備用於治療呼吸道疾病之定量噴霧吸入劑的製程方法
FR2973786B1 (fr) * 2011-04-06 2014-07-04 Valois Sas Bague pour dispositif de distribution de produit fluide.
EP2510928A1 (de) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium zur Verbesserung der Schlafqualität bei atemwegserkrankten Patienten
AR086745A1 (es) 2011-06-27 2014-01-22 Parion Sciences Inc 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
WO2013181232A2 (en) 2012-05-29 2013-12-05 Michael Ross Johnson Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases
HUE032891T2 (hu) 2012-12-17 2017-11-28 Parion Sciences Inc Klórpirazin-karboxamid-származékok nem kielégítõ nyálkahártya-hidratáció által elõsegített megbetegedések kezelésére
ES2674665T3 (es) 2012-12-17 2018-07-03 Parion Sciences, Inc. Compuestos de 3,5-diamino-6-cloro-N-(N-(4-fenilbutilo)carbamimidoilo)-pirazina-2-carboxamida
RU2671976C2 (ru) 2012-12-17 2018-11-08 Пэрион Сайенсиз, Инк. Соединения 3,5-диамино-6-хлор-n-(n-(4-фенилбутил)карбамимидоил)пиразин-2-карбоксамида
CN105473133A (zh) 2013-04-30 2016-04-06 欧缇托匹克公司 干粉制剂及使用方法
PL3104853T3 (pl) 2014-02-10 2020-05-18 Respivant Sciences Gmbh Leczenie stabilizatorami komórek tucznych zaburzeń ogólnoustrojowych
JP2017505348A (ja) 2014-02-10 2017-02-16 パタラ ファーマ リミテッド ライアビリティ カンパニー 肺疾患治療のための肥満細胞安定剤
GB201402513D0 (en) 2014-02-13 2014-04-02 Cardiff Scintigraphics Ltd Pressurised metered dose inhalers and method of manufacture
EP3107548B8 (de) 2014-02-20 2022-07-20 Otitopic Inc. Trockenpulverformulierungen zur inhalation
CA2991760C (en) 2014-07-31 2025-05-06 Aspeya US Inc. DRY INHALATION POWDER FORMULATIONS
WO2017027387A1 (en) 2015-08-07 2017-02-16 Patara Pharma, LLC Methods for the treatment of mast cell related disorders with mast cell stabilizers
US10265296B2 (en) 2015-08-07 2019-04-23 Respivant Sciences Gmbh Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
JP2019528320A (ja) 2016-08-31 2019-10-10 レシュピファント サイエンシス ゲゼルシャフト ミット ベシュレンクター ハフトゥングRespivant Sciences Gmbh 特発性肺線維症による慢性咳の治療のためのクロモリン組成物
EP3522983A4 (de) 2016-10-07 2020-06-03 Respivant Sciences GmbH Cromolynzusammensetzung zur behandlung von lungenfibrose
CN107529499B (zh) * 2017-04-20 2020-06-09 苏州康乐辉医药科技有限公司 一种气雾剂药液浓度稳定装置
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices
WO2023138670A1 (en) * 2022-01-21 2023-07-27 The University Of Hong Kong Dual targeting powder formulation of antiviral agent for nasal and lung deposition through single intranasal administration

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3046863A1 (de) 1980-12-12 1982-07-22 Robert Bosch Gmbh, 7000 Stuttgart Elektronisch gesteuertes kraftstoffzumesssystem fuer eine brennkraftmaschine
GB8613811D0 (en) * 1986-06-06 1986-07-09 Phares Pharm Res Nv Composition & method
GB8828477D0 (en) 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
EP0460064A4 (en) * 1989-02-23 1992-04-01 Rorer International (Holdings) Inc. Therapeutic aerosol formulations
CH680263A5 (de) 1989-07-20 1992-07-31 Norman Godin
JP2854974B2 (ja) 1990-06-29 1999-02-10 フアイソンズ・ピーエルシー 加圧エアロゾル組成物
ATE114112T1 (de) 1990-10-18 1994-12-15 Minnesota Mining & Mfg Aerosolzubereitung, die beclometason 17,21- dipropionat enthält.
GB9024366D0 (en) 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
EP0561166A1 (de) 1992-03-17 1993-09-22 ASTA Medica Aktiengesellschaft Dosieraerosole enthaltend den Wirkstoff D-18024 und verwandte Strukturen
WO1993025193A1 (fr) * 1992-06-12 1993-12-23 Teijin Limited Preparation pharmaceutique destinee a etre administree par les voies respiratoires
KR100321649B1 (ko) * 1993-03-17 2002-07-22 미네소타 마이닝 앤드 매뉴팩춰링 캄파니 에스테르,아미드또는머캅토에스테르로부터유도된분산보조제를함유하는에어로졸제제
GB9404945D0 (en) 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
GB9419269D0 (en) * 1994-09-23 1994-11-09 Unilever Plc Aerosol
GB9426252D0 (en) * 1994-12-24 1995-02-22 Glaxo Group Ltd Pharmaceutical composition
RU2101054C1 (ru) 1996-04-30 1998-01-10 Закрытое акционерное общество "Техно-ТМ" Аэрозолеобразующий состав для тушения пожаров и способ его получения
GEP20043260B (en) * 1998-03-16 2004-06-25 Nectar Therapeutics Aerosolized Active Agent Delivery and Device for Realization Thereof
GB9807232D0 (en) 1998-04-03 1998-06-03 Univ Cardiff Aerosol composition
US6136294C1 (en) 1998-09-22 2002-09-24 Aeropharm Technology Inc Amino acid stabilized medical aerosol formulation

Also Published As

Publication number Publication date
MXPA00009660A (es) 2003-07-14
AU761518B2 (en) 2003-06-05
KR20010072563A (ko) 2001-07-31
BR9909394A (pt) 2000-12-05
AU3162099A (en) 1999-10-25
ID27586A (id) 2001-04-12
WO1999051205A1 (en) 1999-10-14
CA2327336C (en) 2008-07-08
CN1303270A (zh) 2001-07-11
EP1069887B8 (de) 2010-08-25
JP2002510614A (ja) 2002-04-09
GB9807232D0 (en) 1998-06-03
US20050249674A1 (en) 2005-11-10
IL138770A0 (en) 2001-10-31
US6737044B1 (en) 2004-05-18
ZA200005374B (en) 2002-01-03
CN1215832C (zh) 2005-08-24
DE69942606D1 (de) 2010-09-02
ES2349184T3 (es) 2010-12-28
EP1069887B1 (de) 2010-07-21
CA2327336A1 (en) 1999-10-14
EP1069887A1 (de) 2001-01-24
US7481995B2 (en) 2009-01-27

Similar Documents

Publication Publication Date Title
DE69942606D1 (de) Aerosol-zusammensetzung
MY119074A (en) Pharmaceutical aerosol composition
DK1137399T3 (da) Forbedringer af eller vedrørende pulvere
IT1254974B (it) Granulati compositi, scorrevoli,idrofobi,un procedimento per la loro preparazione nonche' loro impiego
DE60226613D1 (de) Darreichungsformen welche mikropartikel und treibgas enthalten
EP0812968A3 (de) Isolierendes Baumaterial
WO2003024396A3 (en) Dry powder medicament formulations
CA2179645A1 (en) Ultrafine reactive silica particles, suspension containing the same, and hard coating composition
ATE217856T1 (de) Kombination aus microfasern und mineralteilchen, herstellung und verwendungen
NZ508797A (en) Particles of HCV envelope proteins: use for vaccination
KR900009728A (ko) 수성도료 조성물 및 이의 용도
CA2151967A1 (en) Magnetic nanocomposite compositions and processes for the preparation and use thereof
SE9701278L (sv) Pulverformigt biogent, av förbenade hjort framställt preparat och på det biogena preparatet baserad livsmedelstillsats
AU9313198A (en) Gas generant compositions, methods of production of the same and devices made therefrom
AU3388997A (en) Inhaler apparatus with modified surfaces for enhanced release of dry powders
WO2003059317A3 (en) Medicinal aerosol compositions with a functionalized polyethyleneglycol excipient
MY101327A (en) Grenade body, in particular for hand grenades.
ATE190844T1 (de) Cefixim-zubereitung
ATE224422T1 (de) Expandierte polypropylen-partikel
AR007807A1 (es) Polvo de aspartame para la aplicacion en mezclas de polvos y procedimiento para su preparacion
CA2241039A1 (en) Insulating construction material
KR940003549A (ko) 물리적 경피 흡수촉진제 및 이것을 함유하는 첩부제
Drouillard et al. AE literature- Acousto-ultrasonic reflections
EP0145478A3 (de) Katalysator

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties